OXBDF (OXBDF) Stock Price & Analysis
OXBDF (OXBDF) rose 0.00% to USD 8 as of July 26, 2026 at 08:19 UTC, according to Nexqual real-time market data.
OXBDF last closed at USD 8; the session ranged USD 8–8 on volume of 100 shares. Market capitalization is $968.30M, with a 52-week range of USD 5.17–12.61 (PNK). Source: Nexqual, July 26, 2026 at 08:19 UTC.
Key Statistics (as of July 26, 2026 at 08:19 UTC)
| Price | USD 8 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 8 |
| Open | USD 8 |
| Day Range | USD 8 – 8 |
| 52-Week Range | USD 5.17 – 12.61 |
| Volume | 100 shares |
| Market Cap | $968.30M |
| Exchange | PNK |
Technical Analysis (OXBDF)
Nexqual's technical model rates OXBDF "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 08:19 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 50.15 (neutral) |
| vs SMA50 | Below (USD 8.09) |
| MACD | -0 (negative) |
Analyst Ratings (OXBDF)
Wall Street analysts rate OXBDF "None", per Nexqual as of July 26, 2026 at 08:19 UTC.
| Consensus Rating | None |
|---|
Earnings (OXBDF)
Source: Nexqual, July 26, 2026 at 08:19 UTC.
Financials & Fundamentals (OXBDF)
| Total Revenue | $168.74M |
|---|---|
| Revenue Growth (YoY) | +22.50% |
| Gross Margin | +39.10% |
| Operating Margin | -7.88% |
| Profit Margin | -17.85% |
| ROE | -40.37% |
| Debt / Equity | 162.16 |
| Current Ratio | 2.2 |
| Total Cash | $96.90M |
| Total Debt | $148.13M |
| Free Cash Flow | $-13,250 |
Source: Nexqual, July 26, 2026 at 08:19 UTC.
Financial Health Score (OXBDF)
Nexqual rates OXBDF's overall financial health "Weak" across five dimensions, as of July 26, 2026 at 08:19 UTC.
| Growth | Strong — Revenue +31% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 39%, operating -8% |
| Balance Sheet | Weak — $97M cash vs $148M debt |
| Cash Flow | Weak — FCF negative: -$13K, burning cash |
| Efficiency | Critical — ROE -40%, ROA -7.0% |
Ownership (OXBDF)
| Insider Ownership | +20.55% |
|---|---|
| Institutional Ownership | +55.36% |
| Shares Outstanding | 121.04M |
| Float | 60.83M |
Source: Nexqual, July 26, 2026 at 08:19 UTC.
Leadership (OXBDF)
OXBDF is led by Frank Mathias (age 63), CEO & Director, per Nexqual as of July 26, 2026 at 08:19 UTC.
| CEO & Director | Frank Mathias (age 63) |
|---|---|
| CFO & Director | Lucinda Clair Crabtree (age 46) |
Major Backers & Investors (OXBDF)
Notable institutional backers of OXBDF include abrdn World Healthcare Fund, according to Nexqual as of July 26, 2026 at 08:19 UTC.
Active Investors
| Investor | Stake |
|---|---|
| abrdn World Healthcare Fund | 1.18% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 0.3% |
Source: Nexqual, July 26, 2026 at 08:19 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PHMMF | PHARMA MAR SA | USD 86.09 | ▲ 0% |
| PHGUF | Pharming Group NV | USD 1.3 | ▲ 0% |
| CUVL | Clinuvel Pharmaceuticals Limited American Depositary Shares | USD 6.95 | ▼ 0.71% |
| INRLF | Valneva SE | USD 2.62 | ▲ 0% |
| PTCHF | PureTech Health PLC | USD 1.6 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 08:19 UTC. This page is informational and not investment advice.